Data / Form D filings / KALM Therapeutics, Inc.
KALM Therapeutics, Inc.: Form D filing
KALM Therapeutics, Inc., a biotechnology company in Huntsville, AL, filed a Form D with the SEC in 2024. The latest, on August 9, 2024, reports $590,380 sold of a $590,380 offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6820 MOQUIN DRIVE NW, Huntsville, AL, 35806
- Phone
- (256) 715-9336
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2032945
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 9, 2024 | New notice | $590,380 | $590,380 | 14 | Jul 25, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chris Seibert | Executive Officer, Director | |
| Anuj Singhal | Executive Officer, Director |
Other biotechnology companies in Alabama that filed recently
- Khaya Biosciences, Inc. $200,000 · Aug 13, 2026
Every Form D from the week of Aug 5, 2024 · All recent filings in Alabama · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what KALM Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.